Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

Register using your

PHARMACEUTICAL INDUSTRY back to topic

Cash-Rich Drugmakers Eye M&A

Here's how a new breed of CEOs are approaching dealmaking.

BusinessWeek. Added by Arlene Weintraub on January 23, 2009

report

save

This article has:

Date

Type Channel Author

Search Cancel